Document is current

Any future updates will be listed below

Therapeutic switching of metronidazole anti-cancerous compounds as anti SARS-COV-2 inhibitors: integration of QSAR, molecular docking, MD simulation and ADMET analysis

Crossref DOI link: https://doi.org/10.1007/s11084-024-09653-6

Published Online: 2024-08-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark